Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Prostate Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 44 articles: HTML format Text format

Single Articles

January 2012
1. KING MT , Viney R, Smith DP, Hossain I, et al
   Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer.
   Br J Cancer. 2012 Jan 24. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. BRYANT RJ , Pawlowski T, Catto JW, Marsden G, et al
   Changes in circulating microRNA levels associated with prostate cancer.
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. KETOLA K , Hilvo M, Hyotylainen T, Vuoristo A, et al
   Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.
   Br J Cancer. 2012;106:99-106.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. BASANTA D , Scott JG, Fishman MN, Ayala G, et al
   Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game.
   Br J Cancer. 2011 Dec 1. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. LUDVIGSSON JF , Fall K, Montgomery S
   Risk of prostate cancer in a population-based cohort of men with coeliac disease.
   Br J Cancer. 2011 Dec 1. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
6. SCAGGIANTE B , Dapas B, Bonin S, Grassi M, et al
   Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression.
   Br J Cancer. 2011 Nov 17. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. LARKIN SE , Holmes S, Cree IA, Walker T, et al
   Identification of markers of prostate cancer progression using candidate gene expression.
   Br J Cancer. 2011 Nov 10. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KOJIMA S , Chiyomaru T, Kawakami K, Yoshino H, et al
   Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer.
   Br J Cancer. 2011 Nov 8. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. DAVIES NJ , Batehup L, Thomas R
   The role of diet and physical activity in breast, colorectal, and prostate cancer survivorship: a review of the literature.
   Br J Cancer. 2011;105 Suppl 1:S52-73.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. KHAN NF , Mant D, Carpenter L, Forman D, et al
    Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study.
    Br J Cancer. 2011;105 Suppl 1:S29-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
11. BOUSQUET G , Alexandre J, Le Tourneau C, Goldwasser F, et al
    Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients.
    Br J Cancer. 2011 Oct 25. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. PAYNE H , Mason M
    Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments.
    Br J Cancer. 2011 Oct 18. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. BERMUDO R , Abia D, Mozos A, Garcia-Cruz E, et al
    Highly sensitive molecular diagnosis of prostate cancer using surplus material washed off from biopsy needles.
    Br J Cancer. 2011 Oct 18. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
14. KOTE-JARAI Z , Leongamornlert D, Saunders E, Tymrakiewicz M, et al
    BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
    Br J Cancer. 2011 Sep 27. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. ARMSTRONG K , Ahmad I, Kalna G, Tan SS, et al
    Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer.
    Br J Cancer. 2011 Sep 27. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CATTO JW , Robinson MC, Albertsen PC, Goepel JR, et al
    Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
    Br J Cancer. 2011;105:931-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
17. KOZIOL JA
    New tricks with old dogs: personalised medicine and clinical trials.
    Br J Cancer. 2011;105:599-601.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. DISCACCIATI A , Orsini N, Andersson SO, Andren O, et al
    Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study.
    Br J Cancer. 2011 Aug 16. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. KHEIRANDISH P , Chinegwundoh F
    Ethnic differences in prostate cancer.
    Br J Cancer. 2011;105:481-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. VIJAI J , Kirchhoff T, Gallagher D, Hamel N, et al
    Genetic architecture of prostate cancer in the Ashkenazi Jewish population.
    Br J Cancer. 2011 Aug 9. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
21. CHEEMA M , Sharif A
    Comment on 'Hand pattern indicates risk of prostate cancer'.
    Br J Cancer. 2011;105:466.
    PubMed     Text format     Related articles   
    
    
    
    
22. MULLER DC , Giles GG, Manning JT, Hopper JL, et al
    Second to fourth digit ratio (2D:4D) and prostate cancer risk in the Melbourne Collaborative Cohort Study.
    Br J Cancer. 2011 Jul 5. doi: 10.1038/bjc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
23. WU T , Giovannucci E, Welge J, Mallick P, et al
    Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.
    Br J Cancer. 2011;105:65-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
24. MUKHERJEE R , McGuinness DH, McCall P, Underwood MA, et al
    Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
25. UZOH CC , Holly JM, Biernacka KM, Persad RA, et al
    Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. PASHAYAN N , Duffy SW, Chowdhury S, Dent T, et al
    Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
27. ZAMAN MS , Chen Y, Deng G, Shahryari V, et al
    The functional significance of microRNA-145 in prostate cancer.
    Br J Cancer. 2011;104:892.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
28. RUMSBY M , Schmitt J, Sharrard M, Rodrigues G, et al
    Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C.
    Br J Cancer. 2011;104:673-84.
    PubMed     Text format     Related articles   
    
    
    
    
29. SHAMASH J , Powles T, Sarker SJ, Protheroe A, et al
    A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. PETRIOLI R , Pascucci A, Conca R, Chiriaco G, et al
    Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KANG BH , Tavecchio M, Goel HL, Hsieh CC, et al
    Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
32. DIMITROPOULOU P , Martin RM, Turner EL, Lane JA, et al
    Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. RAMSAY AK , McCracken SR, Soofi M, Fleming J, et al
    ERK5 signalling in prostate cancer promotes an invasive phenotype.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SHIIREVNYAMBA A , Takahashi T, Shan H, Ogawa H, et al
    Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts.
    Br J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
35. RAHMAN AA , Lophatananon A, Brown SS, Harriss D, et al
    Hand pattern indicates prostate cancer risk.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
36. SCHAYOWITZ A , Sabnis G, Goloubeva O, Njar VC, et al
    Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
37. EDWARDS SM , Evans DG, Hope Q, Norman AR, et al
    Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. HAO J , Chen H, Madigan MC, Cozzi PJ, et al
    Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. TENG Y , Ren MQ, Cheney R, Sharma S, et al
    Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. PENG G , Hakim M, Broza YY, Billan S, et al
    Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors.
    Br J Cancer. 2010;103:542-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
41. GUPTA A , Roobol MJ, Savage CJ, Peltola M, et al
    A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MOLIFE LR , Fong PC, Paccagnella L, Reid AH, et al
    The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.
    Br J Cancer. 2010;103:332-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. DUDDERIDGE TJ , Kelly JD, Wollenschlaeger A, Okoturo O, et al
    Diagnosis of prostate cancer by detection of minichromosome maintenance 5 protein in urine sediments.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CORCORAN NM , Hovens CM, Michael M, Rosenthal MA, et al
    Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.
    Br J Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: